Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Sportoletti, Paolo  [Clear All Filters]
2023
Sportoletti P, Laurenti L, Chiarenza A, Gaidano G, Albi E, Mauro FRomana, Trentin L, Vallisa D, Pane F, Cuneo A, et al. Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. Hematol Oncol. 2023.
2022
Fresa A, Autore F, Piciocchi A, Catania G, Visentin A, Tomasso A, Moretti M, Vitale C, Chiarenza A, Morelli F, et al. Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. Blood Adv. 2022;6(13):3875-3878.
2021
Morabito F, Tripepi G, Del Poeta G, Mauro FRomana, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Varettoni M, et al. Assessment of the 4-factor score: retrospective analysis of 586 cll patients receiving ibrutinib. A campus cll study. Am J Hematol. 2021.
Falini B, Sportoletti P, Sorcini D. BCOR gene alterations in hematological diseases. Blood. 2021.
Morabito F, Tripepi G, Del Poeta G, Mauro FRomana, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Bossio S, et al. Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials. Am J Hematol. 2021.
Morabito F, Del Poeta G, Mauro FRomana, Reda G, Sportoletti P, Laurenti L, Coscia M, Herishanu Y, Bossio S, Varettoni M, et al. TP53 disruption as a risk factor in the era of targeted therapies: a multicenter retrospective study of 525 chronic lymphocytic leukemia cases. Am J Hematol. 2021.
2019
Innocenti I, Morelli F, Autore F, Piciocchi A, Frustaci A, Mauro FR, Schiattone L, Trentin L, Del Poeta G, Reda G, et al. Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience. Br J Haematol. 2019.
2018
Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang Y-H, Ramabadran R, Gionfriddo I, Mezzasoma F, Milano F, Nabet B, et al. Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell. 2018;34(3):499-512.e9.
2015
Guarnerio J, Riccardi L, Taulli R, Maeda T, Wang G, Hobbs RM, Song MSup, Sportoletti P, Bernardi R, Bronson RT, et al. A genetic platform to model sarcomagenesis from primary adult mesenchymal stem cells. Cancer Discov. 2015.